60 Degrees Pharmaceuticals, Inc. Common Stock

SXTP

60 Degrees Pharmaceuticals, Inc. (SXTP) is a biopharmaceutical company focused on developing innovative therapies primarily targeting cancer and other serious medical conditions. The company emphasizes research and development to bring novel treatment options to market, leveraging advanced scientific approaches to improve patient outcomes.

$0.97 -0.01 (-0.74%)
🚫 60 Degrees Pharmaceuticals, Inc. Common Stock does not pay dividends

Company News

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results
GlobeNewswire Inc. • 60 Degrees Pharmaceuticals • November 13, 2025

60 Degrees Pharmaceuticals reported Q3 2025 financial results with 223% net product revenue increase, but experienced a gross loss due to inventory write-off. The company is exploring new treatment indications for tafenoquine, including potential treatments for canine babesiosis and chronic babesiosis.

SXTPW
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings
Benzinga • Rishabh Mishra • January 29, 2025

U.S. stock futures were mixed ahead of the Federal Reserve's interest rate decision and key earnings reports from major tech companies. Investors are cautious as they await the Fed's policy announcement and guidance.

TSLAMSFTMETASBUXSYKSXTPW

Related Companies

Sensient Technology Corporation
Sensient Technology Corporation
SXT
China SXT Pharmaceuticals, Inc. Ordinary Shares
China SXT Pharmaceuticals, Inc. Ordinary Shares
SXTC
So-Young International Inc. American Depository Shares
So-Young International Inc. American Depository Shares
SY
60 Degrees Pharmaceuticals, Inc. Warrant
SXTPW